Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2000 Jun;44(6):1512-7.
doi: 10.1128/AAC.44.6.1512-1517.2000.

Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis

K N Sorensen  1 , R A Sobel, K V Clemons, D Pappagianis, D A Stevens, P L Williams
Affiliations
Comparative Study

Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis

K N Sorensen et al. Antimicrob Agents Chemother. 2000 Jun.

Abstract

Coccidioidal meningitis is a devastating disease that requires long-term therapy with little hope of cure. A rabbit model of coccidioidal meningitis was used to compare the therapeutic efficacies of fluconazole (FCZ) and itraconazole (ITZ). Hydrocortisone-treated male New Zealand white rabbits were infected intracisternally with 5.0x10(4) to 5.4x10(4) arthroconidia of Coccidioides immitis. Oral treatment with polyethylene glycol 200 (PEG) (n = 9), FCZ (n = 8; 80 mg/kg of body weight/day), or ITZ (n = 8; 80 mg/kg/day) began 5 days after infection and continued for 28 consecutive days. Both FCZ and ITZ reduced the number of CFU of C. immitis organisms in the spinal cord and brain compared with the number in PEG-treated animals (P< or =0.003), but the results for FCZ and ITZ were not different from each other. Histopathologic severity (semiquantitative scoring system by an observer blinded to treatment) was equally reduced in both FCZ and ITZ treatment groups compared with that in controls (P< or =0.0004). Both treatments resulted in lower cerebrospinal fluid (CSF) protein concentrations and leukocyte counts and faster clearing of C. immitis from CSF compared with the results for PEG-treated controls. Neither drug affected CSF glucose levels. Both compounds were effective at reducing neurological and systemic signs and extending survival (P< or =0.014). FCZ was more effective at reducing head and body shakes, posture changes, and incontinence; ITZ was more effective at reducing continuous fever. Mean levels of FCZ and ITZ in the serum and CSF were determined by bioassay; at 17 to 26 h postdosing, levels were 28.1 to 40.0 and 22.4 to 29.9 microg/ml, respectively, for FCZ and 0.77 to 2.51 and 0 microg/ml, respectively, for ITZ. The sera of most animals developed antibody to C. immitis, but azole treatment attenuated antibody development in CSF and its titer. In conclusion, both FCZ and ITZ were efficacious, but neither was curative in a rabbit model of coccidioidal meningitis.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Survival of rabbits infected intracisternally with C. immitis arthroconidia. The animals were treated once daily starting 5 days after infection with either PEG (□, n = 9), FCZ at 80 mg/kg (◊, n = 8), or ITZ at 80 mg/kg (○, n = 8).
FIG. 2
FIG. 2
Mean number of CFU of C. immitis recovered from spinal cord and brains. C.I., confidence interval.
FIG. 3
FIG. 3
Systemic and neurological signs observed in rabbits infected intracisternally with C. immitis.
FIG. 4
FIG. 4
Mean posture scores observed in rabbits infected intracisternally with C. immitis. Scoring is described in the Materials and Methods.
See this image and copyright information in PMC

References

    1. Arndt C A S, Walsh T J, McCully C L, Balis F M, Pizzo P A, Poplack D G. Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system. J Infect Dis. 1988;157:178–180. - PubMed
    1. Brammer K W, Farrow P R, Faulkner J K. Pharmacokinetics and tissue penetration of fluconazole in humans. Rev Infect Dis. 1990;12(Suppl. 3):S318–S326. - PubMed
    1. Clemons K V, Hanson L H, Perlman A M, Stevens D A. Efficacy of SCH39304 and fluconazole in a murine model of disseminated coccidioidomycosis. Antimicrob Agents Chemother. 1990;34:928–930. - PMC - PubMed
    1. Craven P C, Graybill J R, Jorgensen J H, Dismukes W E, Levine B E. High-dose ketoconazole for treatment of fungal infections of the central nervous system. Ann Intern Med. 1983;98:160–167. - PubMed
    1. Dewsnup D H, Galgiani J N, Graybill J R, Diaz M, Rendon A, Cloud G A, Stevens D A. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Ann Intern Med. 1996;124:305–310. - PubMed

Publication types